Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes

BACKGROUND: In addition to improving survival outcomes, new oncology treatments should lead to amelioration of patients’ quality of life (QoL). Herein, we examined whether QoL results correlated with PFS and OS outcomes in phase III randomized controlled trials (RCTs) investigating new systemic trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Servetto, Alberto, Di Maio, Massimo, Salomone, Fabio, Napolitano, Fabiana, Paratore, Chiara, Di Costanzo, Fabrizio, Viscardi, Giuseppe, Santaniello, Antonio, Formisano, Luigi, Bianco, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318754/
https://www.ncbi.nlm.nih.gov/pubmed/37400832
http://dx.doi.org/10.1186/s12916-023-02953-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318754/
https://www.ncbi.nlm.nih.gov/pubmed/37400832
http://dx.doi.org/10.1186/s12916-023-02953-0

Ejemplares similares